Association of American Cancer Institutes

Association of American Cancer Institutes
Name	Association of American Cancer Institutes
Abbreviation	AACI
Formation	1991
Type	Professional association
Headquarters	Washington, D.C.
Region served	United States
Membership	Cancer centers
Leader title	President

Association of American Cancer Institutes is a non-profit association representing leading cancer centers in the United States and Canada, coordinating collaboration among academic, medical, and research institutions such as Johns Hopkins Hospital, Mayo Clinic, and MD Anderson Cancer Center. The organization functions as a convening body for clinical trial networks, translational research programs, and policy engagement with agencies like the National Cancer Institute, National Institutes of Health, and Food and Drug Administration. AACI facilitates shared initiatives across member centers including protocol harmonization with entities such as American Society of Clinical Oncology and partnerships with philanthropic organizations including American Cancer Society and Susan G. Komen.

History

The association emerged amid a landscape shaped by milestones like the establishment of the National Cancer Act of 1971 and expansion of the National Cancer Institute-designated Cancer Centers Program, forming a formal consortium in the early 1990s to respond to trends exemplified by the growth of translational research at institutions such as Dana–Farber Cancer Institute and Fred Hutchinson Cancer Research Center. Early activities paralleled cooperative networks including the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group, aligning member centers to address multi-center trial logistics, cooperative group integration, and standardized data sharing influenced by initiatives like The Cancer Genome Atlas. Over subsequent decades AACI adapted to regulatory shifts tied to the Affordable Care Act debates, negotiated priorities with the Institute of Medicine and interacted with advocacy movements epitomized by organizations such as Relay For Life.

Membership and Structure

AACI’s membership comprises a spectrum of institutions from comprehensive centers like UCLA Health and Memorial Sloan Kettering Cancer Center to regional centers affiliated with universities such as University of Michigan Hospitals and University of Texas Southwestern Medical Center. Governance is conducted through an elected board and executive committee with representation reflecting centers modeled after Commission on Cancer accreditation and Association of American Medical Colleges norms, incorporating committees for clinical research, finance, and communications. Member engagement occurs through working groups tied to specific programs at centers like Pediatric Oncology Group-affiliated hospitals and cross-institution platforms resembling the Clinical Trials Network approach used by cooperative groups such as Southwest Oncology Group.

Research and Clinical Programs

The association promotes multi-institutional research efforts encompassing precision oncology studies informed by discoveries from projects like The Cancer Genome Atlas and drug development collaborations that mirror partnerships with pharmaceutical companies including Pfizer and Merck & Co.. Member centers run phase I–III clinical trials, biobanking initiatives comparable to programs at Broad Institute-partnering centers, and molecular tumor boards using methodologies developed at Stanford Cancer Institute and Cold Spring Harbor Laboratory. AACI facilitates data harmonization akin to efforts by European Genome-phenome Archive collaborators and supports participation in networks resembling the NCI Community Oncology Research Program to extend clinical access beyond metropolitan centers to regional partners such as MUSC Health.

Education and Training

AACI supports graduate medical education and postdoctoral training programs hosted by institutions like Harvard Medical School, Columbia University Irving Medical Center, and Yale School of Medicine, promoting curricula that integrate clinical exposure at centers including Cleveland Clinic and basic science mentorship modeled after programs at Salk Institute. Training initiatives emphasize interdisciplinary fellowships in medical oncology, surgical oncology, and radiation oncology anchored in the traditions of Society of Surgical Oncology and American Board of Radiology standards, and encourage career development awards patterned on mechanisms from the National Institutes of Health. Cooperative educational symposia bring together leaders from American Association for Cancer Research, American Society of Hematology, and specialty societies to deliver continuing medical education and training modules.

Advocacy and Policy

The association engages in policy advocacy addressing research funding, reimbursement, and regulatory pathways by coordinating positions with stakeholders such as the Congressional Cancer Caucus, Office of Management and Budget, and federal agencies including the Centers for Medicare & Medicaid Services. AACI’s policy work features testimony and commentaries on appropriations for the National Cancer Institute and legislative matters reminiscent of debates around the 21st Century Cures Act, while partnering with patient advocacy organizations like Lung Cancer Foundation of America and Ovarian Cancer Research Alliance to shape priority agendas. The association also works on policy responses to public health emergencies in coordination with entities such as Centers for Disease Control and Prevention and state health departments.

Funding and Grants

Member centers secure diversified funding streams from federal sources including grants from the National Institutes of Health and NCI program project grants, foundation awards from organizations like Howard Hughes Medical Institute, and philanthropic gifts comparable to major campaigns at St. Jude Children's Research Hospital. AACI assists members in navigating grant mechanisms such as R01, P01, and U54 awards and provides guidance on industry-sponsored trial contracts with companies like Bristol Myers Squibb and Novartis. The association also helps centers pursue collaborative funding opportunities through consortia patterned after international collaborations with institutions like Wellcome Trust and Cancer Research UK.

Category:Cancer organizations in the United States Category:Medical associations